These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 3966978
21. Selective dissociation and characterization of cells from different regions of multicell tumor spheroids. Freyer JP, Sutherland RM. Cancer Res; 1980 Nov; 40(11):3956-65. PubMed ID: 7471046 [Abstract] [Full Text] [Related]
22. Enhancement of thermal killing by polyamines V. The response of EMT6 multicellular tumour spheroids versus monolayer cells. Ben-Hur E, Shaw JJ, Bleehen NM. Br J Cancer; 1983 Jan; 47(1):51-5. PubMed ID: 6821633 [Abstract] [Full Text] [Related]
23. Resistance of MGH-U1 bladder cancer spheroids to vincristine. Erlichman C, Wu A. Anticancer Res; 1992 Jan; 12(4):1233-6. PubMed ID: 1503414 [Abstract] [Full Text] [Related]
24. The effect of adriamycin and 4'-deoxydoxorubicin on cell survival of human lung tumour cells grown in monolayer and as spheroids. Kerr DJ, Wheldon TE, Kerr AM, Freshney RI, Kaye SB. Br J Cancer; 1986 Sep; 54(3):423-9. PubMed ID: 3756078 [Abstract] [Full Text] [Related]
25. Effect of cell density on intracellular adriamycin concentration and cytotoxicity in exponential and plateau phase EMT6 cells. Chambers SH, Bleehen NM, Watson JV. Br J Cancer; 1984 Mar; 49(3):301-6. PubMed ID: 6704304 [Abstract] [Full Text] [Related]
26. Exploiting tumor hypoxia through bioreductive release of diffusible cytotoxins: the cobalt(III)-nitrogen mustard complex SN 24771. Wilson WR, Moselen JW, Cliffe S, Denny WA, Ware DC. Int J Radiat Oncol Biol Phys; 1994 May 15; 29(2):323-7. PubMed ID: 8195027 [Abstract] [Full Text] [Related]
27. In vitro analysis of the response of multicellular tumor spheroids exposed to chemotherapeutic agents in vitro or in vivo. Yuhas JM, Tarleton AE, Harman JG. Cancer Res; 1978 Nov 15; 38(11 Pt 1):3595-8. PubMed ID: 698922 [Abstract] [Full Text] [Related]
28. Potentiation of CCNU toxicity by AF-2 in V79 spheroids: implications for mechanisms of chemosensitization. Durand RE, Olive PL. Int J Radiat Oncol Biol Phys; 1986 Aug 15; 12(8):1375-8. PubMed ID: 3759558 [Abstract] [Full Text] [Related]
29. Radiation response of human melanoma multicellular spheroids measured as single cell survival, growth delay, and spheroid cure: comparisons with the parent tumor xenograft. Rofstad EK, Wahl A, Brustad T. Int J Radiat Oncol Biol Phys; 1986 Jun 15; 12(6):975-82. PubMed ID: 3721939 [Abstract] [Full Text] [Related]
30. Cytotoxicity of hypoxic cell sensitizers in multicell spheroids. Sutherland RM, Bareham BJ, Reich KA. Cancer Clin Trials; 1980 Jun 15; 3(1):73-83. PubMed ID: 7389039 [Abstract] [Full Text] [Related]
31. CB 1954 revisited. II. Toxicity and antitumour activity. Workman P, Morgan JE, Talbot K, Wright KA, Donaldson J, Twentyman PR. Cancer Chemother Pharmacol; 1986 Jun 15; 16(1):9-14. PubMed ID: 3940225 [Abstract] [Full Text] [Related]
32. Cytotoxic drug penetration studies in multicellular tumour spheroids. Kerr DJ, Wheldon TE, Hydns S, Kaye SB. Xenobiotica; 1988 Jun 15; 18(6):641-8. PubMed ID: 3166552 [Abstract] [Full Text] [Related]
33. The radiation response of hypoxic cells in EMT6 spheroids in suspension culture does model data from EMT6 tumors. Franko AJ, Koch CJ. Radiat Res; 1983 Dec 15; 96(3):497-504. PubMed ID: 6657918 [Abstract] [Full Text] [Related]
34. The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour. Twentyman PR, Bleehen NM. Br J Cancer; 1976 Mar 15; 33(3):320-8. PubMed ID: 57788 [Abstract] [Full Text] [Related]
35. Recovery from potentially lethal damage and recruitment time of noncycling clonogenic cells in 9L confluent monolayers and spheroids. Rodriguez A, Alpen EL, Mendonca M, DeGuzman RJ. Radiat Res; 1988 Jun 15; 114(3):515-27. PubMed ID: 3375440 [Abstract] [Full Text] [Related]
36. Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing. Zhang X, Wang W, Yu W, Xie Y, Zhang X, Zhang Y, Ma X. Biotechnol Prog; 2005 Jun 15; 21(4):1289-96. PubMed ID: 16080713 [Abstract] [Full Text] [Related]
37. The in vitro effects and cross-resistance patterns of some novel anthracyclines. Twentyman PR, Fox NE, Wright KA, Workman P, Broadhurst MJ, Martin JA, Bleehen NM. Br J Cancer; 1986 May 15; 53(5):585-94. PubMed ID: 3459509 [Abstract] [Full Text] [Related]
38. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain. Hirst DG, Brown JM, Hazlehurst JL. Br J Cancer; 1982 Jul 15; 46(1):109-16. PubMed ID: 7201845 [Abstract] [Full Text] [Related]
39. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer. Kessel S, Cribbes S, Bonasu S, Rice W, Qiu J, Chan LL. Cytometry A; 2017 Sep 15; 91(9):883-892. PubMed ID: 28618188 [Abstract] [Full Text] [Related]
40. Specific (EMT6) and non-specific (WEHI-164) cytolytic activity by host cells infiltrating tumour spheroids. Wilson KM, Lord EM. Br J Cancer; 1987 Feb 15; 55(2):141-6. PubMed ID: 3493024 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]